Yao K, Shentu X, Jiang J, Du X
Eye Center, Second Affiliated Hospital of Zhejiang University, Hangzhou, China.
Eur J Ophthalmol. 2002 May-Jun;12(3):200-4. doi: 10.1177/112067210201200305.
To evaluate the clinical outcome of vitrectomy with phacofragmentation without perfluorocarbon liquid (PFCL) in the management of dislocation of the crystalline lens, caused by trauma, hereditary disorders, or hypermature cataracts, and lens fragments due to phacoemulsification.
A prospective study was conducted to evaluate 30 eyes of 29 patients who had undergone standard pars plana vitrectomy with phacofragmentation without PFCL in the vitreous cavity, for the removal of dislocated crystalline lenses or lens fragments, from January 1998 to July 2000. All cases were followed for more than six months.
Final best corrected visual acuity of 0.5 or better increased from 0% preoperatively to 36.7% postoperatively, and 0.2 or better rose to 76.7%. The mean IOP was significant reduced, from 26.35 mmHg to 12.75 mmHg. No intraoperative complications occurred. Although two eyes (6.7%) developed retinal detachment, one (3.3%) had cystoid macular edema (CME) and one (3.3%) had a transient intraocular pressure increase (to 25 mmHg) postoperatively, all others had a favorable outcome.
Standard pars plana vitrectomy with phacofragmentation without PFCL in the vitreous cavity is a safe, simple, and effective method for removing a dislocated crystalline lens or lens fragments, with good visual outcome.
评估在处理由外伤、遗传性疾病或过熟期白内障导致的晶状体脱位以及超声乳化术后晶状体碎片时,不使用全氟碳液体(PFCL)的玻璃体切割联合晶状体超声粉碎术的临床效果。
进行一项前瞻性研究,以评估1998年1月至2000年7月期间29例患者的30只眼,这些患者接受了标准的经平坦部玻璃体切割联合晶状体超声粉碎术,术中未在玻璃体腔使用PFCL,以移除脱位的晶状体或晶状体碎片。所有病例均随访超过6个月。
最终最佳矫正视力达到0.5或更好的比例从术前的0%提高到术后的36.7%,达到0.2或更好的比例从术前的0%提高到术后的76.7%。平均眼压显著降低,从26.35 mmHg降至12.75 mmHg。术中未发生并发症。尽管有2只眼(6.7%)术后发生视网膜脱离,1只眼(3.3%)出现黄斑囊样水肿(CME),1只眼(3.3%)术后眼压短暂升高(至25 mmHg),但其他所有患者预后良好。
在玻璃体腔不使用PFCL的标准经平坦部玻璃体切割联合晶状体超声粉碎术是一种安全、简单且有效的方法,用于移除脱位的晶状体或晶状体碎片,视觉效果良好。